Biomea Fusion Stock Book Value Per Share
| BMEA Stock | USD 10.98 0.15 1.39% |
Biomea Fusion fundamentals help investors to digest information that contributes to Biomea Fusion's financial success or failures. It also enables traders to predict the movement of Biomea Stock. The fundamental analysis module provides a way to measure Biomea Fusion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomea Fusion stock.
| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.34 | 2.34 | |
| Tangible Book Value Per Share | 3.34 | 2.34 |
Biomea | Book Value Per Share |
Biomea Fusion Company Book Value Per Share Analysis
Biomea Fusion's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Biomea Fusion Book Value Per Share | 4.72 X |
Most of Biomea Fusion's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomea Fusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biomea Book Value Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Biomea Fusion is extremely important. It helps to project a fair market value of Biomea Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Biomea Fusion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomea Fusion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomea Fusion's interrelated accounts and indicators.
Click cells to compare fundamentals
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
Biomea Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, the book value per share of Biomea Fusion is about 4.719 times. This is 377.59% lower than that of the Biotechnology sector and 101.9% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.76% higher than that of the company.
Biomea Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomea Fusion's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics of similar companies.Biomea Fusion is currently under evaluation in book value per share category among related companies.
Biomea Fundamentals
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | 227.5 M | ||||
| Shares Outstanding | 35.89 M | ||||
| Shares Owned By Insiders | 25.18 % | ||||
| Shares Owned By Institutions | 87.09 % | ||||
| Number Of Shares Shorted | 13.24 M | ||||
| Price To Book | 2.75 X | ||||
| EBITDA | (124.62 M) | ||||
| Net Income | (117.25 M) | ||||
| Cash And Equivalents | 149.63 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 2.29 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 16.46 X | ||||
| Book Value Per Share | 4.72 X | ||||
| Cash Flow From Operations | (96.59 M) | ||||
| Short Ratio | 10.40 X | ||||
| Earnings Per Share | (3.44) X | ||||
| Target Price | 54.43 | ||||
| Number Of Employees | 103 | ||||
| Beta | -0.54 | ||||
| Market Capitalization | 394.07 M | ||||
| Total Asset | 199.93 M | ||||
| Retained Earnings | (248.82 M) | ||||
| Working Capital | 156.32 M | ||||
| Net Asset | 199.93 M |
About Biomea Fusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biomea Fusion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.Moving against Biomea Stock
| 0.79 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.72 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.65 | ELYM | Eliem Therapeutics | PairCorr |
| 0.62 | XFOR | X4 Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | NRSNW | NeuroSense Therapeutics | PairCorr |
The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biomea Fusion Piotroski F Score and Biomea Fusion Altman Z Score analysis. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.Note that the Biomea Fusion information on this page should be used as a complementary analysis to other Biomea Fusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Biomea Fusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.44) | Return On Assets (0.48) | Return On Equity (0.84) |
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.